Rigel Pharmaceuticals  

1180 Veterans Blvd.
South San Francisco,  CA  94080

United States
http://www.rigel.com/
  • Booth: 23151

Rigel Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, developing and providing targeted small molecule drugs that significantly improve the lives of patients with immunological disorders in hematology, oncology and rare diseases. We have several development programs with fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, including a phase 3 program in chronic immune thrombocytopenia (ITP) and phase 2 programs in autoimmune hemolytic anemia and in IgA nephropathy. We also have development programs with partners targeting AXL, TGF beta and MDM2.


  •  
  •      
     

  •  
  •